I. Odenholt

发表

The Use of CRP Tests in Patients with Respiratory Tract Infections in Primary Care in Sweden Can Be Questioned

M. André, Å. Schwan, I. Odenholt, 2004, Scandinavian journal of infectious diseases.

Pharmacodynamic studies of trovafloxacin and grepafloxacin in vitro against Gram-positive and Gram-negative bacteria.

T. Cars, I. Odenholt, E. Lowdin, 2000, The Journal of antimicrobial chemotherapy.

Duration of colonization with extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea

I. Odenholt, E. Melander, M. Walder, 2012, Scandinavian journal of infectious diseases.

Prevalence of extended-spectrum beta-lactamase-producing bacteria in food

I. Odenholt, E. Melander, M. Walder, 2012, Infection and drug resistance.

Pharmacodynamic Studies of Vancomycin, Metronidazole and Fusidic Acid against Clostridium difficile

I. Odenholt, M. Walder, M. Wullt, 2007, Chemotherapy.

Pharmacodynamic effects of subinhibitory antibiotic concentrations.

I. Odenholt, 2001, International journal of antimicrobial agents.

Perception of Risk Factors for Infusion Phlebitis Among Swedish Nurses: A Questionnaire Study

I. Odenholt, O. Paulsen, P. Lanbeck, 2004, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis.

K. Riesbeck, I. Odenholt, P. Lanbeck, 2004, The Journal of antimicrobial chemotherapy.

Dicloxacillin: A Higher Risk than Cloxacillin for Infusion Phlebitis

I. Odenholt, O. Paulsen, P. Lanbeck, 2003, Scandinavian journal of infectious diseases.

Antibiotics Differ in Their Tendency to Cause Infusion Phlebitis: A Prospective Observational Study

I. Odenholt, O. Paulsen, P. Lanbeck, 2002, Scandinavian journal of infectious diseases.

An Audit-Based, Infectious Disease Specialist-Guided Antimicrobial Stewardship Program Profoundly Reduced Antibiotic Use Without Negatively Affecting Patient Outcomes

F. Månsson, I. Odenholt, F. Resman, 2015, Open forum infectious diseases.

Selection of Resistant Streptococcus pneumoniae during Penicillin Treatment In Vitro and in Three Animal Models

O. Cars, I. Odenholt, S. Gudmundsson, 2003, Antimicrobial Agents and Chemotherapy.

Penicillin Pharmacodynamics in Four Experimental Pneumococcal Infection Models

O. Cars, I. Odenholt, K. Fuursted, 2001, Antimicrobial Agents and Chemotherapy.

Antibiotic prophylaxis in surgery: summary of a Swedish-Norwegian Consensus Conference.

B. Beermann, M. Jóhannsson, I. Odenholt, 1998, Scandinavian journal of infectious diseases.

A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea.

I. Odenholt, M. Wullt, 2004, The Journal of antimicrobial chemotherapy.

Bacterial aetiology in ventilator-associated pneumonia at a Swedish university hospital

I. Odenholt, E. Melander, M. Walder, 2010, Scandinavian journal of infectious diseases.

Postantibiotic and bactericidal effect of imipenem againstPseudomonas aeruginosa

O. Cars, I. Odenholt, L. Nilsson, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

Repeated nationwide point-prevalence surveys of antimicrobial use in Swedish hospitals: data for actions 2003-2010.

O. Cars, I. Odenholt, J. Struwe, 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing.

A. MacGowan, I. Odenholt, M. Steinbakk, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Risk Factors for Pneumococcal Carriage in Day Care Centers: A Retrospective Study During a 10-year Period

K. Riesbeck, I. Odenholt, E. Melander, 2014, The Pediatric infectious disease journal.

Suboptimal Antibiotic Dosage as a Risk Factor for Selection of Penicillin-Resistant Streptococcus pneumoniae: In Vitro Kinetic Model

O. Cars, I. Odenholt, I. Gustafsson, 2003, Antimicrobial Agents and Chemotherapy.

Studies of the killing kinetics of benzylpenicillin, cefuroxime, azithromycin, and sparfloxacin on bacteria in the postantibiotic phase

O. Cars, I. Odenholt, E. Löwdin, 1997, Antimicrobial agents and chemotherapy.

Lactobacillus plantarum 299v Enhances the Concentrations of Fecal Short-Chain Fatty Acids in Patients with Recurrent Clostridium difficile-Associated Diarrhea

I. Odenholt, M. Wullt, A. Berggren, 2007, Digestive Diseases and Sciences.

Postantibiotic, Postantibiotic Sub-MIC, and Subinhibitory Effects of PGE-9509924, Ciprofloxacin, and Levofloxacin

O. Cars, I. Odenholt, E. Löwdin, 2003, Antimicrobial Agents and Chemotherapy.

Diagnosis-prescribing surveys in 2000, 2002 and 2005 in Swedish general practice: Consultations, diagnosis, diagnostics and treatment choices

M. André, Å. Schwan, I. Odenholt, 2008, Scandinavian journal of infectious diseases.

Postantibiotic and Sub-MIC Effects of Benzylpenicillin against Streptococcus pneumoniae with Different Susceptibilities for Penicillin

I. Odenholt, I. Gustafsson, E. Löwdin, 2003, Chemotherapy.

Necrotizing myositis and septic shock caused by Haemophilus influenzae type f in a previously healthy man diagnosed with an IgG3 and a mannose-binding lectin deficiency

K. Riesbeck, I. Odenholt, F. Resman, 2011, Scandinavian journal of infectious diseases.

Hydrogen Peroxide Vapor Decontamination in a Patient Room Using Feline Calicivirus and Murine Norovirus as Surrogate Markers for Human Norovirus

A. Widell, N. Uzcátegui, I. Odenholt, 2016, Infection Control & Hospital Epidemiology.

Frequent Emergence of Resistance in Clostridium difficile during Treatment of C. difficile-Associated Diarrhea with Fusidic Acid

T. Åkerlund, I. Odenholt, L. Burman, 2006, Antimicrobial Agents and Chemotherapy.

Management of urinary tract infections in primary care: A repeated 1-week diagnosis-prescribing study in five counties in Sweden in 2000 and 2002

M. André, I. Odenholt, C. Lundborg, 2004, Scandinavian journal of infectious diseases.

High incidence of septic shock caused by Streptococcus pneumoniae serotype 3 - a retrospective epidemiological study

A. Forsgren, K. Riesbeck, I. Odenholt, 2013, BMC Infectious Diseases.

Endotoxin release from Escherichia coli after exposure to tobramycin: dose-dependency and reduction in cefuroxime-induced endotoxin release.

J. Bring, I. Odenholt, M. Lundholm, 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Variation in the Propensity to Release Endotoxin after Cefuroxime Exposure in Different Gram-negative Bacteria: Uniform and Dose-dependent Reduction by the Addition of Tobramycin

I. Odenholt, M. Lundholm, J. Sjölin, 2003, Scandinavian journal of infectious diseases.

Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimens.

O. Cars, I. Odenholt, E. Löwdin, 2004, The Journal of antimicrobial chemotherapy.

Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.

O. Cars, I. Odenholt, 2006, The Journal of antimicrobial chemotherapy.

In Vitro Studies of Pharmacodynamic Properties of Vancomycin against Staphylococcus aureus andStaphylococcus epidermidis

O. Cars, I. Odenholt, E. Löwdin, 1998, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of Telithromycin In Vitro against Respiratory Tract Pathogens

O. Cars, I. Odenholt, E. Löwdin, 2001, Antimicrobial Agents and Chemotherapy.

Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model

O. Cars, I. Odenholt, S. Bengtsson, 1996, Antimicrobial agents and chemotherapy.

Effects of supra- and sub-MIC benzylpenicillin concentrations on group A beta-haemolytic streptococci during the postantibiotic phase in vivo.

O. Cars, I. Odenholt, S. Holm, 1990, The Journal of antimicrobial chemotherapy.

Effects of benzylpenicillin on Streptococcus pyogenes during the postantibiotic phase in vitro.

O. Cars, I. Odenholt, S. Holm, 1989, The Journal of antimicrobial chemotherapy.

An in vivo model for evaluation of the postantibiotic effect.

O. Cars, I. Odenholt, S. Holm, 1988, Scandinavian journal of infectious diseases.

In Vitro Pharmacodynamic Studies of L-749,345 in Comparison with Imipenem and Ceftriaxone against Gram-Positive and Gram-Negative Bacteria

O. Cars, I. Odenholt, E. Löwdin, 1998, Antimicrobial Agents and Chemotherapy.

Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria.

O. Cars, I. Odenholt, E. Löwdin, 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

EUCAST technical note on tigecycline.

A. MacGowan, I. Odenholt, M. Steinbakk, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

model.in a newly developed in vitro kinetic benzylpenicillin against Streptococcus Pharmacodynamic effects of sub-MICs of

O. Cars, I. Odenholt, E. Löwdin, 2013 .

In vitro studies of the pharmacodynamics of teicoplanin against Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium.

O. Cars, I. Odenholt, E. Löwdin, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Eradication of nasopharyngeal carriage of penicillin-non-susceptible Streptococcus pneumoniae—is it possible?

I. Odenholt, M. Hellberg, S. Johansson, 2012, Scandinavian journal of infectious diseases.

Pharmacokinetic and Pharmacodynamic Parameters for Antimicrobial Effects of Cefotaxime and Amoxicillin in an In Vitro Kinetic Model

O. Cars, I. Odenholt, I. Gustafsson, 2001, Antimicrobial Agents and Chemotherapy.

Assessment of early combination effects of colistin and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii in dynamic time-kill experiments

O. Cars, I. Odenholt, L. Friberg, 2017, Infectious diseases.

Effect of step-down therapy of ceftriaxone plus loracarbef versus parenteral therapy of ceftriaxone on the intestinal microflora in patients with community-acquired pneumonia.

I. Odenholt, C. Nord, I. Nilsson-ehle, 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Increase of β-Lactam-Resistant Invasive Haemophilus influenzae in Sweden, 1997 to 2010

A. Forsgren, K. Riesbeck, I. Odenholt, 2012, Antimicrobial Agents and Chemotherapy.

Lactobacillus plantarum 299v for the Treatment of Recurrent Clostridium difficile-associated Diarrhoea: A Double-blind, Placebo-controlled Trial

I. Odenholt, M. Wullt, M. Hagslätt, 2003, Scandinavian journal of infectious diseases.

The management of infections in children in general practice in Sweden: A repeated 1-week diagnosis-prescribing study in 5 counties in 2000 and 2002

M. André, I. Odenholt, A. Jacobsson, 2005, Scandinavian journal of infectious diseases.

Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea

I. Odenholt, A. Brolund, E. Melander, 2010, Scandinavian journal of infectious diseases.

Activity of Three Disinfectants and Acidified Nitrite Against Clostridium difficile Spores

I. Odenholt, M. Walder, M. Wullt, 2003, Infection Control & Hospital Epidemiology.

Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden

I. Odenholt, E. Melander, M. Walder, 2011, European Journal of Clinical Microbiology & Infectious Diseases.

Risk factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden

I. Odenholt, E. Melander, M. Walder, 2013, Infection and drug resistance.

Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum β-lactamase-producing Escherichia coli bacteraemia

I. Odenholt, J. Tham, N. Lund, 2014, Scandinavian journal of infectious diseases.

Pharmacodynamic Effects of Telavancin against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Strains in the Presence of Human Albumin or Serum and in an In Vitro Kinetic Model

O. Cars, I. Odenholt, E. Löwdin, 2007, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: a comparison of different dosage regimens including a pharmacokinetically enhanced formulation.

O. Cars, I. Odenholt, E. Löwdin, 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Differences in Antibiotic Prescribing Patterns Between General Practitioners in Scandinavia: A Questionnaire Study

I. Odenholt, K. Rokstad, S. Mölstad, 2002, Scandinavian journal of infectious diseases.

Epidemiology of MRSA in southern Sweden: strong relation to foreign country of origin, health care abroad and foreign travel

I. Odenholt, A.-K. Larsson, E. Melander, 2013, European Journal of Clinical Microbiology & Infectious Diseases.

Upper Respiratory Tract Infections in General Practice: Diagnosis, Antibiotic Prescribing, Duration of Symptoms and Use of Diagnostic Tests

M. André, Å. Schwan, I. Odenholt, 2002, Scandinavian journal of infectious diseases.

Duration of methicillin-resistant Staphylococcus aureus colonization after diagnosis: A four-year experience from southern Sweden

I. Odenholt, A.-K. Larsson, E. Melander, 2011, Scandinavian journal of infectious diseases.

Hydrogen peroxide vapour treatment inactivates norovirus but has limited effect on post-treatment viral RNA levels

A. Widell, K. Riesbeck, I. Odenholt, 2019, Infectious diseases.

Postantibiotic Effect of Meropenem and Ciprofloxacin in the Presence of 5-Fluorouracil

I. Odenholt, B. Ljungberg, I. Nilsson-ehle, 2002, Chemotherapy.

Bactericidal Effect of Combinations of Antibiotic and Antineoplastic Agents against Staphylococcus aureus and Escherichia coli

I. Odenholt, B. Ljungberg, I. Nilsson-ehle, 2002, Chemotherapy.

A prospective, randomized, multicenter comparative study of clinafloxacin versus a ceftriaxone-based regimen in the treatment of hospitalized patients with community-acquired pneumonia.

I. Odenholt, K. Tack, W. Petermann, 2001, Scandinavian journal of infectious diseases.

Bactericidal effects of levofloxacin in comparison with those of ciprofloxacin and sparfloxacin.

O. Cars, I. Odenholt, E. Löwdin, 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Duration of methicillin-resistant Staphylococcus aureus colonization after diagnosis: A four-year experience from southern Sweden

I. Odenholt, A.-K. Larsson, E. Melander, 2011, Scandinavian journal of infectious diseases.

Prevalence of penicillin-non-susceptible Streptococcus pneumoniae in children in day-care centres subjected to an intervention to prevent dispersion

K. Riesbeck, I. Odenholt, E. Melander, 2015, Infectious diseases.

Increase of β-Lactam-Resistant Invasive Haemophilus influenzae in Sweden, 1997 to 2010

A. Forsgren, K. Riesbeck, I. Odenholt, 2012, Antimicrobial Agents and Chemotherapy.